Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xifeng Zhitong
- Development stage
- Phase 3
- Lead developer
- Guangxi Qiangshou Pharmaceutical Group
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Xifeng Zhitong is a Traditional Chinese Medicine (TCM) product developed by Guangxi Qiangshou Pharmaceutical Group, primarily indicated for the treatment of migraines and headaches associated with liver-yang hyperactivity and internal wind. Formulated as tablets or capsules, it typically contains a blend of botanical extracts such as Gastrodia elata and Uncaria rhynchophylla. The therapeutic approach focuses on extinguishing wind and calming the liver to provide analgesic effects and reduce the frequency of vascular headaches. It is widely used in China as a standard treatment for chronic migraine management.
- Brand names
- Xifeng Zhitong
- Other names
- Xifeng Zhitong PianXifeng Zhitong JiaonangXifeng Zhitong TabletXifeng Zhitong Capsule
Beyond the preview
Go deeper on Xifeng Zhitong.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xifeng Zhitong.